ProShares Ultra Nasdaq Biotechnology (BIB) Leverage/Terbalik
$109,80
▼ -0,67 (-0,61%)
Perubahan 1 hari
$62,04 – $126,40
Rentang 52 minggu
Data kepemilikan belum tersedia untuk dana ini.
BIB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 2 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -9,84% | ▼ -9,78% |
| 3M | ▲ +2,77% | ▲ +2,84% |
| 6M | ▲ +34,28% | ▲ +34,37% |
| YTD | ▲ +37,63% | ▲ +37,74% |
| 1Y | ▲ +73,21% | ▲ +73,64% |
| 3Y | ▲ +135,47% | ▲ +142,03% |
| 5Y | ▲ +20,16% | ▲ +23,54% |
| Maks | ▲ +1362,31% | ▲ +1406,10% |
Volatilitas 1T42,75%
Volatilitas 3Y41,86%
Penurunan Maksimum 3Y
-45,99%
Beta 3Y0,85
Sharpe 1Y*1,50
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Bulan lalu (Mei 2026)
-$4.8M
Kuartal berakhir Mei 2026
-$13.9M
12 bulan terakhir
-$12.0M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 267 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| WaVe Life Sciences Ltd. | · | $46K | 0,06 | 6.960 | EC | SG |
| Compass Pathways plc | 20451W101 | $46K | 0,06 | 3.487 | EC | GB |
| Personalis, Inc. | 71535D106 | $44K | 0,06 | 3.869 | EC | US |
| MannKind Corp. | 56400P706 | $43K | 0,06 | 11.389 | EC | US |
| EyePoint, Inc. | 30233G209 | $42K | 0,06 | 3.062 | EC | US |
| Alvotech SA | · | $41K | 0,06 | 12.210 | EC | LU |
| Collegium Pharmaceutical, Inc. | 19459J104 | $39K | 0,05 | 1.172 | EC | US |
| Savara, Inc. | 805111101 | $39K | 0,05 | 7.524 | EC | US |
| Olema Pharmaceuticals, Inc. | 68062P106 | $39K | 0,05 | 2.962 | EC | US |
| Corvus Pharmaceuticals, Inc. | 221015100 | $38K | 0,05 | 3.054 | EC | US |
| Xeris Biopharma Holdings, Inc. | 98422E103 | $38K | 0,05 | 6.134 | EC | US |
| Absci Corp. | 00091E109 | $38K | 0,05 | 5.561 | EC | US |
| Zenas Biopharma, Inc. | 98937L105 | $36K | 0,05 | 1.983 | EC | US |
| Cullinan Therapeutics, Inc. | 230031106 | $36K | 0,05 | 2.185 | EC | US |
| Grifols SA | 398438408 | $35K | 0,05 | 4.510 | EC | ES |
| Pacira BioSciences, Inc. | 695127100 | $35K | 0,05 | 1.495 | EC | US |
| ARS Pharmaceuticals, Inc. | 82835W108 | $33K | 0,05 | 3.656 | EC | US |
| Janux Therapeutics, Inc. | 47103J105 | $33K | 0,04 | 2.251 | EC | US |
| Kura Oncology, Inc. | 50127T109 | $33K | 0,04 | 3.218 | EC | US |
| Sana Biotechnology, Inc. | 799566104 | $33K | 0,04 | 9.849 | EC | US |
| Arbutus Biopharma Corp. | 03879J100 | $32K | 0,04 | 7.110 | EC | CA |
| Xencor, Inc. | 98401F105 | $32K | 0,04 | 2.711 | EC | US |
| MeiraGTx Holdings plc | · | $32K | 0,04 | 2.975 | EC | KY |
| Amphastar Pharmaceuticals, Inc. | 03209R103 | $32K | 0,04 | 1.677 | EC | US |
| ORIC Pharmaceuticals, Inc. | 68622P109 | $31K | 0,04 | 3.711 | EC | US |
| Eton Pharmaceuticals, Inc. | 29772L108 | $30K | 0,04 | 992 | EC | US |
| Theravance Biopharma, Inc. | · | $30K | 0,04 | 1.875 | EC | KY |
| Mesoblast Ltd. | 590717401 | $30K | 0,04 | 1.934 | EC | AU |
| Geron Corp. | 374163103 | $30K | 0,04 | 23.602 | EC | US |
| Annexon, Inc. | 03589W102 | $29K | 0,04 | 5.349 | EC | US |
| Omeros Corp. | 682143102 | $29K | 0,04 | 2.622 | EC | US |
| Phathom Pharmaceuticals, Inc. | 71722W107 | $28K | 0,04 | 2.912 | EC | US |
| BioAge Labs, Inc. | 09077V100 | $28K | 0,04 | 1.604 | EC | US |
| Esperion Therapeutics, Inc. | 29664W105 | $28K | 0,04 | 8.837 | EC | US |
| Replimune Group, Inc. | 76029N106 | $27K | 0,04 | 3.053 | EC | US |
| Maravai LifeSciences Holdings, Inc. | 56600D107 | $26K | 0,04 | 5.410 | EC | US |
| CorMedix, Inc. | 21900C308 | $25K | 0,03 | 2.911 | EC | US |
| Zevra Therapeutics, Inc. | 488445206 | $24K | 0,03 | 2.083 | EC | US |
| Prime Medicine, Inc. | 74168J101 | $24K | 0,03 | 6.673 | EC | US |
| Phibro Animal Health Corp. | 71742Q106 | $23K | 0,03 | 763 | EC | US |
| Castle Biosciences, Inc. | 14843C105 | $23K | 0,03 | 1.100 | EC | US |
| Vor BioPharma, Inc. | 929033207 | $23K | 0,03 | 1.536 | EC | US |
| CytomX Therapeutics, Inc. | 23284F105 | $23K | 0,03 | 6.265 | EC | US |
| Candel Therapeutics, Inc. | 137404109 | $22K | 0,03 | 2.707 | EC | US |
| Zai Lab Ltd. | 98887Q104 | $22K | 0,03 | 1.269 | EC | KY |
| Design Therapeutics, Inc. | 25056L103 | $22K | 0,03 | 2.105 | EC | US |
| Tectonic Therapeutic, Inc. | 878972108 | $22K | 0,03 | 693 | EC | US |
| Ironwood Pharmaceuticals, Inc. | 46333X108 | $22K | 0,03 | 6.028 | EC | US |
| Arvinas, Inc. | 04335A105 | $21K | 0,03 | 2.363 | EC | US |
| Solid Biosciences, Inc. | 83422E204 | $21K | 0,03 | 2.880 | EC | US |
Dividen 13 pembayaran
0,20%Imbal hasil TTM
$0,23Pembayaran TTM / saham
Kuartalan
(est.)
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 23 Sep. 2026 | $0,0830 |
| 25 Maret 2026 | $0,0070 |
| 24 Des. 2025 | $0,1350 |
| 24 Sep. 2025 | $0,1810 |
| 25 Juni 2025 | $0,1710 |
| 26 Maret 2025 | $0,1310 |
| 23 Des. 2024 | $0,3960 |
| 25 Sep. 2024 | $0,1530 |
| 26 Juni 2024 | $0,2650 |
| 20 Maret 2024 | $0,0400 |
| 20 Des. 2023 | $0,0380 |
| 22 Des. 2022 | $0,0200 |
| 21 Sep. 2010 | $0,0110 |
Pemilik institusional (13F) 22 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785.973 | 21,94% | 7.802 | Saham | 30 Juni 2026 |
| Capital Investment Advisors, LLC | $599.013 | 16,72% | 5.946 | Saham | 30 Juni 2026 |
| Kaizen Financial Strategies | $535.554 | 14,95% | 5.315 | Saham | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413.034 | 11,53% | 4.100 | Opsi beli | 30 Juni 2026 |
| Palumbo Wealth Management LLC | $402.960 | 11,25% | 4.000 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $302.220 | 8,44% | 3.000 | Opsi beli | 30 Juni 2026 |
| Jump Financial, LLC | $257.189 | 7,18% | 2.553 | Saham | 30 Juni 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102.957 | 2,87% | 1.022 | Saham | 30 Juni 2026 |
| FRANKLIN RESOURCES INC | $70.115 | 1,96% | 696 | Saham | 30 Juni 2026 |
| PNC Financial Services Group, Inc. | $50.370 | 1,41% | 500 | Saham | 30 Juni 2026 |
| Ashton Thomas Private Wealth, LLC | $37.576 | 1,05% | 373 | Saham | 30 Juni 2026 |
| Truvestments Capital LLC | $12.593 | 0,35% | 125 | Saham | 30 Juni 2026 |
| Axiom Investment Management LLC | $5.037 | 0,14% | 50 | Saham | 30 Juni 2026 |
| Qube Research & Technologies Ltd | $4.936 | 0,14% | 49 | Saham | 30 Juni 2026 |
| SIMPLEX TRADING, LLC | $1.309 | 0,04% | 13 | Saham | 30 Juni 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0,01% | 2.400 | Saham | 30 Juni 2026 |
| Rockefeller Capital Management L.P. | $201 | 0,01% | 2 | Saham | 30 Juni 2026 |
| MORGAN STANLEY | $131 | 0,00% | 1 | Saham | 30 Juni 2026 |
| UBS Group AG | $101 | 0,00% | 1 | Saham | 30 Juni 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0,00% | 1 | Saham | 30 Juni 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0,00% | 198 | Saham | 30 Juni 2026 |
| ROYAL BANK OF CANADA | $0 | 0,00% | 1 | Saham | 30 Juni 2026 |